| MC 2524 Benzobicyclon, [bicyclooctane ring-2,4-14C]- | |
| ([3-(2-Chloro-4-methylsulfonylbenzoyl)-4-phenylthio]bicyclo[3.2.1]oct-3-en-2-one, [bicyclooctane ring-2,4-14C]-) | |
|
MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram
|
|
| Solid | |
| > 30 mCi(1.11 GBq)/mmol | 10 μCi (370 kBq) $1240 |
| NextGen V-Vial - shipped on dry ice | 50 μCi (1.85 MBq) $3970 |
| M.W. 446.97 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
| MC 2523 Benzobicyclon, [chlorophenyl-14C(U)]- | |
| ([3-(2-Chloro-4-methylsulfonylbenzoyl)-4-phenylthio]bicyclo[3.2.1]oct-3-en-2-one, [chlorophenyl-14C(U)]-) | |
|
MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram
|
|
| Acetone solution, 100 µCi/ml | |
| > 50 mCi(1.85 GBq)/mmol | 10 μCi (370 kBq) $1240 |
| Sealed ampoule - shipped on dry ice | 50 μCi (1.85 MBq) $3970 |
| M.W. 446.97 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |